{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T21:27:20Z","timestamp":1790976440782,"version":"4.1.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.3816\/cbc.2009.n.021","type":"journal-article","created":{"date-parts":[[2009,5,11]],"date-time":"2009-05-11T21:05:13Z","timestamp":1242075913000},"page":"118-121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Bevacizumab and Paclitaxel for Breast Cancer Patients with Central Nervous System Metastases: A Case Series"],"prefix":"10.3816","volume":"9","author":[{"given":"Sana Intidhar","family":"Labidi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Bachelot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Ray-Coquard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Mosbah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Treilleux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Fayette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Favier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Galy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Yves","family":"Blay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Guastalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.3816\/CBC.2009.n.021_bib1","first-page":"21","article-title":"Management of brain metastases from breast carcinoma","volume":"7","author":"Flowers","year":"1993","journal-title":"Oncology (Williston Park)"},{"key":"10.3816\/CBC.2009.n.021_bib2","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1002\/cncr.23088","article-title":"Clinicopathologic characteristics and prognostic factors in 420 metastatic breast cancer patients with central nervous system metastasis","volume":"110","author":"Altundag","year":"2007","journal-title":"Cancer"},{"key":"10.3816\/CBC.2009.n.021_bib3","first-page":"119","article-title":"Pegylated liposomal doxorubicin plus temozolomide in the salvage treatment of brain metastases: a feasibility study","volume":"22","author":"Del Prete","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.3816\/CBC.2009.n.021_bib4","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/cncr.22127","article-title":"Phase I study of capecitabine in combination with temozolomide in the treatment of patients with brain metastases from breast carcinoma","volume":"107","author":"Rivera","year":"2006","journal-title":"Cancer"},{"key":"10.3816\/CBC.2009.n.021_bib5","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1056\/NEJMoa072113","article-title":"Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer","volume":"357","author":"Miller","year":"2007","journal-title":"N Engl J Med"},{"key":"10.3816\/CBC.2009.n.021_bib6","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.1200\/JCO.2007.12.2440","article-title":"Bevacizumab plus irinotecan in recurrent glioblastoma multiforme","volume":"25","author":"Vredenburgh","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.3816\/CBC.2009.n.021_bib7","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1158\/1078-0432.CCR-06-2478","article-title":"Brain metastases: the HER2 paradigm","volume":"13","author":"Lin","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.3816\/CBC.2009.n.021_bib8","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1002\/cncr.11436","article-title":"Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma","volume":"97","author":"Bendell","year":"2003","journal-title":"Cancer"},{"key":"10.3816\/CBC.2009.n.021_bib9","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1471-2407-7-153","article-title":"Adjuvant trastuzumab in the treatment of her-2-positive early breast cancer: a meta-analysis of published randomized trials","volume":"7","author":"Viani","year":"2007","journal-title":"BMC Cancer"},{"key":"10.3816\/CBC.2009.n.021_bib10","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1002\/cncr.23468","article-title":"Survival in patients with brain metastases from breast cancer: the importance of HER-2 status","volume":"112","author":"Eichler","year":"2008","journal-title":"Cancer"},{"issue":"18 suppl","key":"10.3816\/CBC.2009.n.021_bib11","first-page":"3s","article-title":"Phase II trial of lapatinib for brain metastases in patients with HER2+ breast cancer","volume":"24","author":"Lin","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.3816\/CBC.2009.n.021_bib12","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1056\/NEJMoa064320","article-title":"Lapatinib plus capecitabine for HER2-positive advanced breast cancer","volume":"355","author":"Geyer","year":"2006","journal-title":"N Engl J Med"},{"key":"10.3816\/CBC.2009.n.021_bib13","first-page":"S55","article-title":"Clinical characteristics and molecular markers predicting the development and outcome of breast cancer brain metastases","volume":"94","author":"Melisko","year":"2005","journal-title":"Breast Cancer Res Treat"},{"key":"10.3816\/CBC.2009.n.021_bib14","first-page":"160","article-title":"Distribution of 3-HTaxol in the nervous system (NS) and organs of rats","volume":"12","author":"Lesser","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.3816\/CBC.2009.n.021_bib15","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1023\/B:CLIN.0000024761.00373.55","article-title":"Vascular endothelial growth factor expression promotes the growth of breast cancer brain metastases in nude mice","volume":"21","author":"Kim","year":"2004","journal-title":"Clin Exp Metastasis"},{"key":"10.3816\/CBC.2009.n.021_bib16","first-page":"474","article-title":"Chemotherapy for breast cancer brain metastases","volume":"25","author":"Fenner","year":"2002","journal-title":"Onkologie"},{"key":"10.3816\/CBC.2009.n.021_bib17","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/1097-0142(19950715)76:2<232::AID-CNCR2820760212>3.0.CO;2-0","article-title":"Central nervous system progression of metastatic breast cancer in patients treated with paclitaxel","volume":"76","author":"Freilich","year":"1995","journal-title":"Cancer"},{"key":"10.3816\/CBC.2009.n.021_bib18","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1023\/A:1011132609055","article-title":"High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel","volume":"12","author":"Crivellari","year":"2001","journal-title":"Ann Oncol"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820911706553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820911706553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:09:55Z","timestamp":1761512995000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820911706553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S1526820911706553"],"URL":"https:\/\/doi.org\/10.3816\/cbc.2009.n.021","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bevacizumab and Paclitaxel for Breast Cancer Patients with Central Nervous System Metastases: A Case Series","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3816\/CBC.2009.n.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}